Global Gene Corp Private Ltd.

Q1: What is the name of the company mentioned in the text?
A1: The name of the company is Global Gene Corp Private Ltd.

Q2: What is the main objective of Anuva's Genomic Bio/Data Bank?
A2: Anuva's Genomic Bio/Data Bank aims to create a paradigm shift in genomics by collecting genomic data from diverse populations and blending it with data on disease traits to create richer interpretation, ultimately empowering researchers to unlock novel biological pathways for drug discovery.

Q3: What is the problem with the current availability of genomic sequences?
A3: Caucasians comprise 4 out of 5 available genomic sequences for analysis, resulting in a homogeneous dataset that lacks diversity. This limited diversity hinders the potential of genomics and makes it challenging for researchers to create new knowledge.

Q4: Who are some key individuals involved with Anuva?
A4: Key individuals include Dr. Jonathan Picker (Chief Executive Officer), Kushagra Sharma (President & Board Member), Dr. Asmi Shah (Vice President of Data and Technology), Naveen Tewari (Founder & CEO of InMobi group of companies), and Abhishek Kumar (Chairman & Executive Director).

Q5: What is the significance of diversity in genomics?
A5: Diversity is indispensable to unlock the potential of genomics, as it allows researchers to create new knowledge that cannot be achieved with DNA sequence data alone. A diverse dataset enables researchers to identify novel biological pathways and develop more effective treatments.

Q6: What is Anuva's approach to addressing the limitations of current genomic sequences?
A6: Anuva's Genomic Bio/Data Bank collects genomic data from diverse populations and blends it with data on disease traits to create richer interpretation, providing researchers with a more comprehensive understanding of biological pathways and enabling them to develop new treatments.

Q7: What is Dr. Jonathan Picker's background and expertise?
A7: Dr. Jonathan Picker is an affiliate faculty member and clinical geneticist at Boston's Children's Hospital, Harvard Medical School, with 25 years of experience in Pediatrics and Genetics. He specializes in the interface of clinical care and applied genetic and genomic research.

Q8: What is Anuva's focus on translational research?
A8: Anuva is a translational research company that aims to inspire trust by providing researchers with the tools and expertise needed to create new knowledge not possible with DNA sequence data alone. The company empowers researchers to develop new treatments and therapies through its Genomic Bio/Data Bank.

Q9: What is Naveen Tewari's background and experience?
A9: Naveen Tewari is the Founder & CEO of the InMobi group of companies, bringing his expertise in setting up and running techfirst companies to provide strategic and tactical guidance to Anuva. He holds a bachelor’s degree from Indian Institute of Technology, Kanpur and an MBA from Harvard Business School.

Q10: What is Abhishek Kumar's role at Anuva?
A10: Abhishek Kumar serves as the Chairman & Executive Director of Anuva, bringing his extensive experience in acquiring, merging, carving out, and repositioning companies globally. He founded Joulon a KKR company, and has led largescale distributed businesses globally.